Hangzhou, China · Founded 2012 · In IPO Registration
Developer and researcher of new drugs and treatments designed to treat metabolic diseases and cancers. Atom Therapeutics is based in Hangzhou, China and was founded in 2012. Its last reported valuation was $425 million in Aug 2025. It has raised $70 million.
Last reported valuation
$425.1M
Oct 2026
Priced at
—
Total raised
$70.0M
Last round
—
Cap table — not yet on record
Atom Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Atom Therapeutics with a free account
·The complete investor list: 15 names
·Watch Atom Therapeutics: the Monday email on marks, rounds and moves
